Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02445768
,24:30:chronic_disease
at least 6 months post-stroke
2
[ "at", "least", "6", "months", "post-stroke" ]
[ 0, 0, 0, 0, 2 ]
NCT02927639
13:33:chronic_disease
Significant cognitive disability
2
[ "Significant", "cognitive", "disability" ]
[ 0, 2, 2 ]
NCT03135990
33:75:chronic_disease,83:115:chronic_disease,119:144:chronic_disease
A prior or present diagnosis of receptive and expressive language disorder and/or pervasive developmental disorder or severe mental retardation
2
[ "A", "prior", "or", "present", "diagnosis", "of", "receptive", "and", "expressive", "language", "disorder", "and/or", "pervasive", "developmental", "disorder", "or", "severe", "mental", "retardation" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2 ]
NCT00338377
20:39:cancer,41:55:cancer,59:79:cancer,83:105:chronic_disease
Patients must have metastatic melanoma, uveal melanoma or stage III in-transit or regional nodal disease. (Turnstile I)
2
[ "Patients", "must", "have", "metastatic", "melanoma", ",", "uveal", "melanoma", "or", "stage", "III", "in-transit", "or", "regional", "nodal", "disease", ".", "(", "Turnstile", "I", ")" ]
[ 0, 0, 0, 3, 3, 0, 3, 3, 0, 3, 3, 3, 0, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02871349
1:17:chronic_disease
Bradyarrhythmias
2
[ "Bradyarrhythmias" ]
[ 2 ]
NCT02982564
16:41:treatment,,
Have completed adjuvant curative therapy at least two months to 5 years prior to recruitment
2
[ "Have", "completed", "adjuvant", "curative", "therapy", "at", "least", "two", "months", "to", "5", "years", "prior", "to", "recruitment" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02050347
11:64:treatment,,
Available allogeneic activated peripheral blood T cell products with >=15% expression of CD19.CAR-CD28ζ determined by flow cytometry (cell dose is based on total cell numbers and not individual antileukemic cell numbers)
2
[ "Available", "allogeneic", "activated", "peripheral", "blood", "T", "cell", "products", "with", ">", "=15", "%", "expression", "of", "CD19.CAR-CD28ζ", "determined", "by", "flow", "cytometry", "(", "cell", "dose", "is", "based", "on", "total", "cell", "numbers", ...
[ 0, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02120222
3:7:treatment,15:28:treatment,33:38:cancer,,,85:95:cancer
a BRAF and/or MEK inhibitor (if tumor contains the V600E or V600K mutation) for 628 metastatic disease
2
[ "a", "BRAF", "and/or", "MEK", "inhibitor", "(", "if", "tumor", "contains", "the", "V600E", "or", "V600K", "mutation", ")", "for", "628", "metastatic", "disease" ]
[ 0, 1, 0, 1, 1, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT02369900
13:24:treatment,26:34:treatment,36:46:treatment,50:59:treatment
Infusion of epinephrine, dopamine, dobutamine or milrinone at time of enrollment
2
[ "Infusion", "of", "epinephrine", ",", "dopamine", ",", "dobutamine", "or", "milrinone", "at", "time", "of", "enrollment" ]
[ 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT01983228
,58:78:chronic_disease
must be able to communicate effectively by telephone (no cognitive disability)
2
[ "must", "be", "able", "to", "communicate", "effectively", "by", "telephone", "(", "no", "cognitive", "disability", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0 ]
NCT02319369
37:62:treatment
Is able and willing to provide bone marrow biopsies/aspirates as requested by the protocol
2
[ "Is", "able", "and", "willing", "to", "provide", "bone", "marrow", "biopsies/aspirates", "as", "requested", "by", "the", "protocol" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01787487
22:32:cancer,134:144:cancer,146:181:cancer,186:227:cancer
Patients with active malignancy of other type than required for this study, are not eligible with the exception of currently treated basal cell, squamous cell carcinoma of the skin, or carcinoma in situ of the cervix or breast
2
[ "Patients", "with", "active", "malignancy", "of", "other", "type", "than", "required", "for", "this", "study", ",", "are", "not", "eligible", "with", "the", "exception", "of", "currently", "treated", "basal", "cell", ",", "squamous", "cell", "carcinoma", "of",...
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0 ]
NCT02519283
48:51:chronic_disease
Patients deemed by emergency physician to have AHF, who they plan to discharge or hold for brief ED-based observation
2
[ "Patients", "deemed", "by", "emergency", "physician", "to", "have", "AHF", ",", "who", "they", "plan", "to", "discharge", "or", "hold", "for", "brief", "ED-based", "observation" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02124772
68:95:treatment
Must have a disease that is relapsed/refractory to all potentially curative standard treatment regimens
2
[ "Must", "have", "a", "disease", "that", "is", "relapsed/refractory", "to", "all", "potentially", "curative", "standard", "treatment", "regimens" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0 ]
NCT02171104
1:33:chronic_disease
Glycoprotein Metabolic Disorders
2
[ "Glycoprotein", "Metabolic", "Disorders" ]
[ 2, 2, 2 ]
NCT02506192
1:25:chronic_disease
acute Chronic Infections
2
[ "acute", "Chronic", "Infections" ]
[ 2, 2, 2 ]
NCT02106988
43:65:treatment
with active infections requiring specific anti-infective therapy are not eligible until all signs of infections are resolved
2
[ "with", "active", "infections", "requiring", "specific", "anti-infective", "therapy", "are", "not", "eligible", "until", "all", "signs", "of", "infections", "are", "resolved" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02352454
18:38:chronic_disease
Subjects who are cognitively impaired
2
[ "Subjects", "who", "are", "cognitively", "impaired" ]
[ 0, 0, 0, 2, 2 ]
NCT02500407
1:43:treatment,,69:79:treatment,88:108:treatment,112:139:treatment
Autologous stem cell transplantation (SCT) within 100 days prior to study drug, or any prior allogeneic SCT or solid organ transplantation
2
[ "Autologous", "stem", "cell", "transplantation", "(", "SCT", ")", "within", "100", "days", "prior", "to", "study", "drug", ",", "or", "any", "prior", "allogeneic", "SCT", "or", "solid", "organ", "transplantation" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01591356
1:11:chronic_disease
Neuropathy (sensory and motor) =< to CTCAE grade 1
2
[ "Neuropathy", "(", "sensory", "and", "motor", ")", "=", "<", "to", "CTCAE", "grade", "1" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02189798
18:44:chronic_disease,,,,,,,,
Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤65 dB for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 3000, 4,000, and 8,000 Hz) in the contralateral (non-implanted) ear
2
[ "Up", "to", "a", "moderate", "sensorineural", "hearing", "loss", "in", "the", "low-to-mid", "frequencies", "(", "pure", "tone", "average", "≤65", "dB", "for", "125", ",", "250", ",", "500", ",", "and", "1000", "Hz", ")", "and", "a", "severe-to-profound", ...
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT01697371
18:31:cancer,48:58:cancer,107:126:cancer
New radiographic liver lesions consistent with metastases in patients with known pathologically confirmed non-lymphoma cancer
2
[ "New", "radiographic", "liver", "lesions", "consistent", "with", "metastases", "in", "patients", "with", "known", "pathologically", "confirmed", "non-lymphoma", "cancer" ]
[ 0, 0, 3, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT01614197
83:101:chronic_disease
Second or greater relapse B-cell patients are eligible at time of relapse or with refractory disease
2
[ "Second", "or", "greater", "relapse", "B-cell", "patients", "are", "eligible", "at", "time", "of", "relapse", "or", "with", "refractory", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02358681
15:20:treatment,
Receipt of an NSAID within six hours of study drug administration
2
[ "Receipt", "of", "an", "NSAID", "within", "six", "hours", "of", "study", "drug", "administration" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02343042
14:30:chronic_disease,41:63:treatment,65:75:treatment,80:91:treatment,
Uncontrolled active infection requiring parenteral antibiotics, antivirals, or antifungals within one week prior to first dose
2
[ "Uncontrolled", "active", "infection", "requiring", "parenteral", "antibiotics", ",", "antivirals", ",", "or", "antifungals", "within", "one", "week", "prior", "to", "first", "dose" ]
[ 0, 2, 2, 0, 1, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02599922
13:32:chronic_disease
Evidence of degenerative myopia regardless of the refractive error in the study eye
2
[ "Evidence", "of", "degenerative", "myopia", "regardless", "of", "the", "refractive", "error", "in", "the", "study", "eye" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01313533
1:17:chronic_disease
Comorbid illness making 2 year survival unlikely
2
[ "Comorbid", "illness", "making", "2", "year", "survival", "unlikely" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT03159754
17:29:treatment
Patients taking theophylline
2
[ "Patients", "taking", "theophylline" ]
[ 0, 0, 1 ]
NCT02496585
1:17:cancer
Liver metastases
2
[ "Liver", "metastases" ]
[ 3, 3 ]
NCT02192398
31:53:chronic_disease,60:70:chronic_disease,,,105:128:chronic_disease,145:151:chronic_disease,154:181:chronic_disease,183:196:chronic_disease,198:217:chronic_disease,233:240:chronic_disease
Has known pre-existing severe cardiovascular disease (i.e. arrhythmia - prolonged QT interval > 440ms), cerebrovascular disease/accident (i.e., stroke), hepatic or renal impairment, CNS condition, metabolic condition, or history of syncope
2
[ "Has", "known", "pre-existing", "severe", "cardiovascular", "disease", "(", "i.e", ".", "arrhythmia", "-", "prolonged", "QT", "interval", ">", "440ms", ")", ",", "cerebrovascular", "disease/accident", "(", "i.e.", ",", "stroke", ")", ",", "hepatic", "or", "ren...
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 0, 2, 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 2 ]
NCT03037931
1:28:chronic_disease,30:53:chronic_disease,55:80:chronic_disease,85:91:chronic_disease,
Acute myocardial infarction, acute coronary syndrome, transient ischemic attack, or stroke within 30 days of enrollment
2
[ "Acute", "myocardial", "infarction", ",", "acute", "coronary", "syndrome", ",", "transient", "ischemic", "attack", ",", "or", "stroke", "within", "30", "days", "of", "enrollment" ]
[ 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT03088072
21:29:allergy_name
Hypersensitivity to edoxaban
2
[ "Hypersensitivity", "to", "edoxaban" ]
[ 0, 0, 4 ]
NCT00483249
1:17:chronic_disease
Aortic aneurysms
2
[ "Aortic", "aneurysms" ]
[ 2, 2 ]
NCT02012296
,44:96:treatment
a minimum washout of 28 days for any other anticancer therapy prior to first dose of study drug is required (only applicable for phase I)
2
[ "a", "minimum", "washout", "of", "28", "days", "for", "any", "other", "anticancer", "therapy", "prior", "to", "first", "dose", "of", "study", "drug", "is", "required", "(", "only", "applicable", "for", "phase", "I", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02558010
1:18:chronic_disease
Seizure Disorders
2
[ "Seizure", "Disorders" ]
[ 2, 2 ]
NCT02189798
18:44:chronic_disease,,,
Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤65 dB for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 3000, 4,000, and 8,000 Hz) in the ear to be implanted
2
[ "Up", "to", "a", "moderate", "sensorineural", "hearing", "loss", "in", "the", "low-to-mid", "frequencies", "(", "pure", "tone", "average", "≤65", "dB", "for", "125", ",", "250", ",", "500", ",", "and", "1000", "Hz", ")", "and", "a", "severe-to-profound", ...
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02911467
31:58:chronic_disease
Patients with rate-controlled atrial fibrillation/flutter
2
[ "Patients", "with", "rate-controlled", "atrial", "fibrillation/flutter" ]
[ 0, 0, 0, 2, 2 ]
NCT02535832
24:31:chronic_disease,33:40:chronic_disease,44:60:chronic_disease
Clinically significant hepatic, cardiac or renal impairment
2
[ "Clinically", "significant", "hepatic", ",", "cardiac", "or", "renal", "impairment" ]
[ 0, 0, 2, 0, 2, 0, 2, 2 ]
NCT03043807
1:14:treatment,21:33:treatment,35:45:treatment
Antiandrogens (e.g. bicalutamide, nilutamide)
2
[ "Antiandrogens", "(", "e.g", ".", "bicalutamide", ",", "nilutamide", ")" ]
[ 1, 0, 0, 0, 1, 0, 1, 0 ]
NCT02344355
1:8:treatment,,36:43:treatment,47:53:treatment
Therapy must begin ≤ 5 weeks after surgery or biopsy
2
[ "Therapy", "must", "begin", "≤", "5", "weeks", "after", "surgery", "or", "biopsy" ]
[ 1, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT02495415
72:90:treatment,92:105:treatment,110:128:treatment
patients must have fully recovered from the acute toxic effects of all prior chemotherapy, immunotherapy, or radiotherapy prior to entering this study
2
[ "patients", "must", "have", "fully", "recovered", "from", "the", "acute", "toxic", "effects", "of", "all", "prior", "chemotherapy", ",", "immunotherapy", ",", "or", "radiotherapy", "prior", "to", "entering", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT03085485
,59:76:chronic_disease
Clinically stable in the last 4 weeks with no evidence of COPD exacerbation
2
[ "Clinically", "stable", "in", "the", "last", "4", "weeks", "with", "no", "evidence", "of", "COPD", "exacerbation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02332369
1:7:chronic_disease
Iritis
2
[ "Iritis" ]
[ 2 ]
NCT02203513
38:60:treatment
Patients who are receiving any other investigational agents
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03060772
12:25:chronic_disease
History of heart failure
2
[ "History", "of", "heart", "failure" ]
[ 0, 0, 2, 2 ]
NCT02433626
9:16:cancer,18:32:cancer,34:52:cancer,54:65:cancer,70:85:cancer
Part 1: Ovarian, fallopian tube, primary peritoneal, endometrial, or cervical cancer
2
[ "Part", "1", ":", "Ovarian", ",", "fallopian", "tube", ",", "primary", "peritoneal", ",", "endometrial", ",", "or", "cervical", "cancer" ]
[ 0, 0, 0, 3, 0, 3, 3, 0, 3, 3, 0, 3, 0, 0, 3, 3 ]
NCT02574455
21:39:cancer,
patients with other prior malignancies must have had at least a 3-year disease-free interval
2
[ "patients", "with", "other", "prior", "malignancies", "must", "have", "had", "at", "least", "a", "3-year", "disease-free", "interval" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02004028
27:39:treatment,43:55:treatment,118:130:cancer
Participants who have had chemotherapy or radiotherapy any time prior to entering the study or at any prior time for mesothelioma. Patients receiving chemotherapy type drugs for benign conditions can participate in this trial
2
[ "Participants", "who", "have", "had", "chemotherapy", "or", "radiotherapy", "any", "time", "prior", "to", "entering", "the", "study", "or", "at", "any", "prior", "time", "for", "mesothelioma", ".", "Patients", "receiving", "chemotherapy", "type", "drugs", "for",...
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01954576
10:22:treatment,,38:40:treatment,45:70:treatment,82:91:treatment
Received radiotherapy of at least 45 Gy and temozolomide chemotherapy as initial treatment for GBM
2
[ "Received", "radiotherapy", "of", "at", "least", "45", "Gy", "and", "temozolomide", "chemotherapy", "as", "initial", "treatment", "for", "GBM" ]
[ 0, 1, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 1, 0, 0 ]
NCT02098161
76:87:allergy_name
Patients who are not candidates for, intolerant, or relapsed/refractory to ruxolitinib
2
[ "Patients", "who", "are", "not", "candidates", "for", ",", "intolerant", ",", "or", "relapsed/refractory", "to", "ruxolitinib" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT01925378
23:40:chronic_disease,65:68:chronic_disease,108:123:cancer
Patients with a known immunocompromised condition or a positive HIV test. Patients with a prior history of cervical cancer
2
[ "Patients", "with", "a", "known", "immunocompromised", "condition", "or", "a", "positive", "HIV", "test", ".", "Patients", "with", "a", "prior", "history", "of", "cervical", "cancer" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02463305
34:39:chronic_disease,41:48:chronic_disease,50:57:chronic_disease,59:68:chronic_disease,72:82:cancer,128:156:treatment,160:181:treatment
Concomitant major comorbidities (renal, hepatic, cardiac, pulmonary or malignancy) to include any medical conditions requiring therapeutic anti-coagulation or anti-platelet therapy
2
[ "Concomitant", "major", "comorbidities", "(", "renal", ",", "hepatic", ",", "cardiac", ",", "pulmonary", "or", "malignancy", ")", "to", "include", "any", "medical", "conditions", "requiring", "therapeutic", "anti-coagulation", "or", "anti-platelet", "therapy" ]
[ 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 3, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1 ]
NCT02857218
1:18:chronic_disease
severely agitated
2
[ "severely", "agitated" ]
[ 2, 2 ]
NCT02393742
,,34:37:chronic_disease
Body mass index (BMI) >40 kg/m2 (FMD measurements can be inaccurate in severely obese patients)
2
[ "Body", "mass", "index", "(", "BMI", ")", ">", "40", "kg/m2", "(", "FMD", "measurements", "can", "be", "inaccurate", "in", "severely", "obese", "patients", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02400463
34:44:cancer,154:162:treatment,166:191:treatment
Patients with a prior history of malignancy are eligible if their malignancy has been definitely treated or is in remission and does not require ongoing adjuvant or cancer-directed therapies
2
[ "Patients", "with", "a", "prior", "history", "of", "malignancy", "are", "eligible", "if", "their", "malignancy", "has", "been", "definitely", "treated", "or", "is", "in", "remission", "and", "does", "not", "require", "ongoing", "adjuvant", "or", "cancer-directed...
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1 ]
NCT01872975
47:65:cancer
Definitive clinical or radiologic evidence of metastatic disease
2
[ "Definitive", "clinical", "or", "radiologic", "evidence", "of", "metastatic", "disease" ]
[ 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02434809
1:15:chronic_disease
Bronchiectasis in the region of the intended implantation
2
[ "Bronchiectasis", "in", "the", "region", "of", "the", "intended", "implantation" ]
[ 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02148796
1:38:chronic_disease
chronic gastroesophageal reflux (GER) requiring medical treatment
2
[ "chronic", "gastroesophageal", "reflux", "(", "GER", ")", "requiring", "medical", "treatment" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02540330
27:38:allergy_name,86:96:allergy_name,98:105:allergy_name,107:121:allergy_name,127:142:allergy_name
known hypersensitivity to fulvestrant or any of its formulation components including castor oil, alcohol, benzyl alcohol, and benzyl benzoate
2
[ "known", "hypersensitivity", "to", "fulvestrant", "or", "any", "of", "its", "formulation", "components", "including", "castor", "oil", ",", "alcohol", ",", "benzyl", "alcohol", ",", "and", "benzyl", "benzoate" ]
[ 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 4, 0, 4, 4, 0, 0, 0, 0 ]
NCT02843568
1:37:chronic_disease
symptomatic congestive heart failure
2
[ "symptomatic", "congestive", "heart", "failure" ]
[ 2, 2, 2, 2 ]
NCT02564744
34:68:cancer,72:104:cancer
Participants with a diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
2
[ "Participants", "with", "a", "diagnosis", "of", "chronic", "lymphocytic", "leukemia", "(", "CLL", ")", "or", "small", "lymphocytic", "lymphoma", "(", "SLL", ")" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 3, 3, 3, 3, 0, 0 ]
NCT02646787
15:23:chronic_disease,25:34:chronic_disease,50:72:chronic_disease
Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems
2
[ "Demonstrating", "delirium", ",", "psychosis", "or", "any", "form", "of", "Organic", "Brain", "Disorder", "and", "associated", "memory", "problems" ]
[ 0, 2, 0, 2, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT03072238
1:25:chronic_disease,40:77:chronic_disease,79:107:chronic_disease
structural heart disease (e.g., severe left ventricular systolic dysfunction, left ventricular hypertrophy)
2
[ "structural", "heart", "disease", "(", "e.g.", ",", "severe", "left", "ventricular", "systolic", "dysfunction", ",", "left", "ventricular", "hypertrophy", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02457702
35:45:treatment,
Significant weight loss or use of diet pills within previous 6 months
2
[ "Significant", "weight", "loss", "or", "use", "of", "diet", "pills", "within", "previous", "6", "months" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT01481974
58:70:treatment,122:149:treatment,173:194:treatment
Be receiving any investigational drug (a drug other than Treprostinil administered under an IND) or participating in any other investigational study, with the exception of alemtuzumab (Campath)
2
[ "Be", "receiving", "any", "investigational", "drug", "(", "a", "drug", "other", "than", "Treprostinil", "administered", "under", "an", "IND", ")", "or", "participating", "in", "any", "other", "investigational", "study", ",", "with", "the", "exception", "of", "...
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02159495
104:138:treatment
Related donor selection will be conducted in accordance with City of Hope's Department of Hematology & Hematopoietic Cell Transplantation criteria and, in the case of unrelated donor from a transplant center, will comply with the National Marrow Donor Program's (NMDP) donor selection standards
2
[ "Related", "donor", "selection", "will", "be", "conducted", "in", "accordance", "with", "City", "of", "Hope", "'s", "Department", "of", "Hematology", "&", "Hematopoietic", "Cell", "Transplantation", "criteria", "and", ",", "in", "the", "case", "of", "unrelated",...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02765633
26:58:treatment,,
Participation in another investigational therapeutic drug or investigational therapeutic device trial within 30 days of starting study
2
[ "Participation", "in", "another", "investigational", "therapeutic", "drug", "or", "investigational", "therapeutic", "device", "trial", "within", "30", "days", "of", "starting", "study" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02128906
47:67:cancer
Patients with a history of curatively-treated non-HNSCC malignancy
2
[ "Patients", "with", "a", "history", "of", "curatively-treated", "non-HNSCC", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02771626
16:45:treatment
Intolerance to prior anti-PD-1/PD-L1 therapy
2
[ "Intolerance", "to", "prior", "anti-PD-1/PD-L1", "therapy" ]
[ 0, 0, 1, 1, 1 ]
NCT02405078
5:17:treatment,19:31:treatment,33:46:treatment,48:56:treatment,61:84:treatment,89:98:treatment,102:110:cancer,
Any chemotherapy, radiotherapy, immunotherapy, biologic, or investigational therapy for treatment of lymphoma within 14 days prior to treatment
2
[ "Any", "chemotherapy", ",", "radiotherapy", ",", "immunotherapy", ",", "biologic", ",", "or", "investigational", "therapy", "for", "treatment", "of", "lymphoma", "within", "14", "days", "prior", "to", "treatment" ]
[ 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 0, 1, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02250157
1:19:chronic_disease
Measurable disease as per Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 criteria
2
[ "Measurable", "disease", "as", "per", "Response", "Evaluation", "Criteria", "in", "Solid", "Tumors", "(", "RECIST", ")", "Version", "1.1", "criteria" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02360579
1:18:treatment,26:46:treatment,52:64:treatment
Antibiotics (ABX) of the aminoglycoside group (ie, streptomycin, gentamicin); except those who are skin-test negative for gentamicin hypersensitivity
2
[ "Antibiotics", "(", "ABX", ")", "of", "the", "aminoglycoside", "group", "(", "ie", ",", "streptomycin", ",", "gentamicin", ")", ";", "except", "those", "who", "are", "skin-test", "negative", "for", "gentamicin", "hypersensitivity" ]
[ 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02266329
45:54:treatment
Potential participants who have been taking trazodone will undergo a 2-week washout period before beginning the preliminary screening period
2
[ "Potential", "participants", "who", "have", "been", "taking", "trazodone", "will", "undergo", "a", "2-week", "washout", "period", "before", "beginning", "the", "preliminary", "screening", "period" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02466971
30:51:treatment,60:69:treatment,73:79:cancer
Patient is receiving another investigational agent for the treatment of cancer
2
[ "Patient", "is", "receiving", "another", "investigational", "agent", "for", "the", "treatment", "of", "cancer" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 3 ]
NCT02335905
33:44:allergy_name
Has had an allergic reaction to ceftaroline in the past
2
[ "Has", "had", "an", "allergic", "reaction", "to", "ceftaroline", "in", "the", "past" ]
[ 0, 0, 0, 0, 0, 0, 4, 0, 0, 0 ]
NCT01434472
71:86:cancer,88:125:cancer,127:148:cancer,,213:244:treatment
Patients must have a histologically confirmed diagnosis of aggressive B-cell lymphoma (diffuse large B-cell lymphoma [DLBCL], Burkitt lymphoma [BL], etc.) expressing the CD20 antigen and have failed at least one prior standard systemic therapy
2
[ "Patients", "must", "have", "a", "histologically", "confirmed", "diagnosis", "of", "aggressive", "B-cell", "lymphoma", "(", "diffuse", "large", "B-cell", "lymphoma", "[", "DLBCL", "]", ",", "Burkitt", "lymphoma", "[", "BL", "]", ",", "etc", ".", ")", "expres...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 3, 3, 3, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT03162731
1:27:cancer,31:54:cancer,86:102:treatment
superficial bladder cancer or in situ cervical cancer that has undergone potentially curative therapy
2
[ "superficial", "bladder", "cancer", "or", "in", "situ", "cervical", "cancer", "that", "has", "undergone", "potentially", "curative", "therapy" ]
[ 3, 3, 3, 0, 3, 3, 3, 3, 0, 0, 0, 0, 1, 1 ]
NCT02346526
21:43:treatment,
No intention to use cytotoxic chemotherapy within the next 6 months
2
[ "No", "intention", "to", "use", "cytotoxic", "chemotherapy", "within", "the", "next", "6", "months" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01270724
15:21:cancer
Patients with ICGCTs who are newly diagnosed
2
[ "Patients", "with", "ICGCTs", "who", "are", "newly", "diagnosed" ]
[ 0, 0, 3, 0, 0, 0, 0 ]
NCT03071692
1:16:chronic_disease,8:16:chronic_disease,,,,,,,,,,409:418:treatment
Type 2 diabetes of longer than 12 weeks duration documented in medical records, for example: local laboratory evidence through medical record review of elevated HbA1c (≥ 6.5% [48 mmol/mol]), elevated plasma glucose (fasting ≥ 126 mg/dL [7.0 mmol/L], 2-hour ≥ 200 mg/dL [11.1 mmol/L] during oral glucose tolerance testing...
2
[ "Type", "2", "diabetes", "of", "longer", "than", "12", "weeks", "duration", "documented", "in", "medical", "records", ",", "for", "example", ":", "local", "laboratory", "evidence", "through", "medical", "record", "review", "of", "elevated", "HbA1c", "(", "≥", ...
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT02500602
25:35:treatment,37:51:treatment,56:84:treatment,
Subjects on maintenance anxiolytic, antidepressant, or mood stabilizing medications which have been initiated during the past four weeks
2
[ "Subjects", "on", "maintenance", "anxiolytic", ",", "antidepressant", ",", "or", "mood", "stabilizing", "medications", "which", "have", "been", "initiated", "during", "the", "past", "four", "weeks" ]
[ 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02058095
13:28:treatment,33:53:chronic_disease,86:96:treatment
Patients on PDEV inhibition for erectile dysfunction who are not willing to stop the medication for the duration of the study
2
[ "Patients", "on", "PDEV", "inhibition", "for", "erectile", "dysfunction", "who", "are", "not", "willing", "to", "stop", "the", "medication", "for", "the", "duration", "of", "the", "study" ]
[ 0, 0, 1, 1, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02474667
1:11:treatment,
Study drug can be administered starting within 30 hours after restoration of blood flow to the engrafted kidney
2
[ "Study", "drug", "can", "be", "administered", "starting", "within", "30", "hours", "after", "restoration", "of", "blood", "flow", "to", "the", "engrafted", "kidney" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01940757
32:45:chronic_disease
Positive confirmatory test for HIV infection
2
[ "Positive", "confirmatory", "test", "for", "HIV", "infection" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02864862
8:29:chronic_disease,31:43:chronic_disease,57:76:treatment
severe parafunctional habits, malocclusion or intent of orthodontic therapy in the future
2
[ "severe", "parafunctional", "habits", ",", "malocclusion", "or", "intent", "of", "orthodontic", "therapy", "in", "the", "future" ]
[ 0, 2, 2, 0, 2, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT01676259
18:28:allergy_name
Known allergy to sesame oil
2
[ "Known", "allergy", "to", "sesame", "oil" ]
[ 0, 0, 0, 4, 4 ]
NCT02514083
,58:67:chronic_disease
Night sweats for more than one month without evidence of infection
2
[ "Night", "sweats", "for", "more", "than", "one", "month", "without", "evidence", "of", "infection" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02122081
24:33:treatment,43:46:cancer,48:51:cancer,55:58:cancer,68:83:treatment
For patients receiving treatment of their AML, MDS or ALL prior to transplantation
2
[ "For", "patients", "receiving", "treatment", "of", "their", "AML", ",", "MDS", "or", "ALL", "prior", "to", "transplantation" ]
[ 0, 0, 0, 1, 0, 0, 3, 0, 3, 0, 3, 0, 0, 1 ]
NCT02709655
17:48:chronic_disease
The patient has Major depressive disorder (MDD), diagnosed according to DSM-5™
2
[ "The", "patient", "has", "Major", "depressive", "disorder", "(", "MDD", ")", ",", "diagnosed", "according", "to", "DSM-5™" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT00887146
21:42:treatment,73:82:treatment,99:107:chronic_disease
Receiving any other investigational agent that would be considered as a treatment for the primary neoplasm
2
[ "Receiving", "any", "other", "investigational", "agent", "that", "would", "be", "considered", "as", "a", "treatment", "for", "the", "primary", "neoplasm" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 2 ]
NCT01684904
71:89:treatment
Surgical consultation to confirm that patient will be able to undergo curative resection after completion of PCT prior to registration
2
[ "Surgical", "consultation", "to", "confirm", "that", "patient", "will", "be", "able", "to", "undergo", "curative", "resection", "after", "completion", "of", "PCT", "prior", "to", "registration" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02207465
19:39:chronic_disease
Unreconstructible SMV/portal occlusion
2
[ "Unreconstructible", "SMV/portal", "occlusion" ]
[ 0, 2, 2 ]
NCT02389309
34:57:chronic_disease,,97:122:chronic_disease,135:158:chronic_disease,165:188:treatment
Patients with evidence of recent intratumoral hemorrhage (within 3 months of study enrollment), gastrointestinal bleeding, history of coronary artery disease or on anticoagulation therapy
2
[ "Patients", "with", "evidence", "of", "recent", "intratumoral", "hemorrhage", "(", "within", "3", "months", "of", "study", "enrollment", ")", ",", "gastrointestinal", "bleeding", ",", "history", "of", "coronary", "artery", "disease", "or", "on", "anticoagulation",...
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 0, 0, 1, 1 ]
NCT01604512
1:15:chronic_disease
Claustrophobia
2
[ "Claustrophobia" ]
[ 2 ]
NCT02219711
14:20:cancer
Other active cancer
2
[ "Other", "active", "cancer" ]
[ 0, 0, 3 ]
NCT02048722
,,,98:104:cancer
Alkaline phosphatase limit =< 2.5 x ULN (=< 5 x ULN for subjects with liver involvement of their cancer)
2
[ "Alkaline", "phosphatase", "limit", "=", "<", "2.5", "x", "ULN", "(", "=", "<", "5", "x", "ULN", "for", "subjects", "with", "liver", "involvement", "of", "their", "cancer", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT02535312
,6:42:treatment
#ERROR!
2
[ "#", "ERROR", "!" ]
[ 1, 1, 1 ]
NCT02509546
21:24:treatment,
Expected to undergo HCT within 120 days of enrollment
2
[ "Expected", "to", "undergo", "HCT", "within", "120", "days", "of", "enrollment" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02914483
1:19:chronic_disease
anginal equivalent symptoms at rest
2
[ "anginal", "equivalent", "symptoms", "at", "rest" ]
[ 2, 2, 0, 0, 0 ]
NCT02172651
25:44:treatment,56:75:treatment,77:92:treatment,94:111:treatment,113:126:treatment,131:153:treatment
Concurrent use of other anti-cancer therapy, including chemotherapy agents, targeted agents, biological agents, immunotherapy, or investigational agents not otherwise specified in this protocol
2
[ "Concurrent", "use", "of", "other", "anti-cancer", "therapy", ",", "including", "chemotherapy", "agents", ",", "targeted", "agents", ",", "biological", "agents", ",", "immunotherapy", ",", "or", "investigational", "agents", "not", "otherwise", "specified", "in", "...
[ 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]